Aerowipe Swab
NDC Package 55305-125-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Aerowipe (sting relief pad) swabs is for adults and children 2 years or older, apply to affected area 3 to 4 times daily. This formulation utilizes a swab delivery system. Marketed by Aero Healthcare Us Llc, this product is identified by NDC 55305-125 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
55305-125-11
Package Description
10 POUCH in 1 BOX / .4 mL in 1 POUCH (55305-125-10)
Product Code
55305-125
11-Digit Billing Format
55305012511
RxNorm Crosswalk
  • RxCUI: 895749 - benzocaine 6 % / isopropyl alcohol 60 % Medicated Pad
  • RxCUI: 895749 - benzocaine 60 MG/ML / isopropyl alcohol 0.6 ML/ML Medicated Pad
  • RxCUI: 895749 - benzocaine 6 % / isopropyl alcohol 60 % Topical Swab

Clinical Specifications

Proprietary Name
Aerowipe
Non-Proprietary Name
Sting Relief Pad
Substance Name
Benzocaine; Isopropyl Alcohol
Dosage Form
Swab - A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
For adults and children 2 years or older, apply to affected area 3 to 4 times daily. For children under 2 years of age, consult a physician before use.

Regulatory & Marketing

Labeler Name
Aero Healthcare Us Llc
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55305-125). Click a package code to view its specific billing and regulatory data.

55305-125-10
.4 mL in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55305-125-11 identifies a specific commercial package of 10 pouch in 1 box / .4 ml in 1 pouch (55305-125-10) of Aerowipe, a human over the counter drug labeled by Aero Healthcare Us Llc. This swab is formulated for topical use and contains benzocaine; isopropyl alcohol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aero Healthcare Us Llc on June 01, 2022. The current certification is valid through December 31, 2026.

How is this Aero Healthcare Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55305012511. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55305-125-11
11-Digit CMS (5-4-2)
55305-0125-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.